These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9544336)

  • 21. Pharmacist 'provider status' legislation introduced into the Senate.
    Young D
    Am J Health Syst Pharm; 2003 Aug; 60(15):1502. PubMed ID: 12951746
    [No Abstract]   [Full Text] [Related]  

  • 22. International Academy of Compounding Pharmacists. Legislative/regulatory update. Preserving patient access--compounders on Capitol Hill 2013!
    Miller DG
    Int J Pharm Compd; 2013; 17(4):302-4. PubMed ID: 24261145
    [No Abstract]   [Full Text] [Related]  

  • 23. Legal cognitive requirements impact on pharmacy practice and patient outcomes.
    Svensberg K; Björnsdottir I; Kälvemark Sporrong S
    Res Social Adm Pharm; 2015; 11(4):590-1. PubMed ID: 25703896
    [No Abstract]   [Full Text] [Related]  

  • 24. Update on state prescribing authority.
    Flanagan ME
    Am Pharm; 1995 Oct; NS35(10):12-8. PubMed ID: 8533705
    [No Abstract]   [Full Text] [Related]  

  • 25. New health care laws will bring changes for pharmacists.
    Thompson CA
    Am J Health Syst Pharm; 2010 May; 67(9):690-5. PubMed ID: 20410538
    [No Abstract]   [Full Text] [Related]  

  • 26. APhA federal pharmacy initiatives: supporting those in harm's way.
    Tackitt RD
    J Am Pharm Assoc (2003); 2007; 47(5):566. PubMed ID: 17848341
    [No Abstract]   [Full Text] [Related]  

  • 27. OBRA's counseling requirement and pharmaceutical care.
    Vinson MC
    Am J Hosp Pharm; 1993 May; 50(5):910-1. PubMed ID: 8506864
    [No Abstract]   [Full Text] [Related]  

  • 28. Which Comes First--Credentialing and Privileging in Pharmacy or Pharmacist Provider Status?
    Bradley-Baker L
    Am J Pharm Educ; 2014 Nov; 78(9):158. PubMed ID: 26056397
    [No Abstract]   [Full Text] [Related]  

  • 29. Evolution of the duty to warn--one state's experience.
    Williams KG
    J Pharm Technol; 1993; 9(4):146-9. PubMed ID: 10128044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacists: a "secret weapon" for reducing drug errors.
    Wiebe C
    MedGenMed; 2007 Apr; 9(2):10. PubMed ID: 17955066
    [No Abstract]   [Full Text] [Related]  

  • 31. Report of the 2009 APhA House of Delegates: actions of the legislative body of the American Pharmacists Association.
    J Am Pharm Assoc (2003); 2009; 49(4):492-4. PubMed ID: 19589759
    [No Abstract]   [Full Text] [Related]  

  • 32. HCFA clarifies 'incident-to' billing by pharmacists.
    Am J Health Syst Pharm; 2000 Sep; 57(17):1557-8. PubMed ID: 10984801
    [No Abstract]   [Full Text] [Related]  

  • 33. CMS chief affirms incident-to billing for pharmacists is allowed.
    Traynor K
    Am J Health Syst Pharm; 2014 Jun; 71(12):977-8. PubMed ID: 24865750
    [No Abstract]   [Full Text] [Related]  

  • 34. This is what your pharmacists can do for you and your patients--let them help.
    Thompson KK
    MedGenMed; 2007 May; 9(2):41. PubMed ID: 17955095
    [No Abstract]   [Full Text] [Related]  

  • 35. [The pharmacist's role in managing medication safety ten year's after the "To err is human" report].
    Otero Lopez MJ
    Farm Hosp; 2010; 34(4):159-62. PubMed ID: 20646942
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter to the editor. The delivery of influenza vaccinations and the role of pharmacists.
    Hayney MS
    Vaccine; 2004 Dec; 23(3):279. PubMed ID: 15530666
    [No Abstract]   [Full Text] [Related]  

  • 37. Federal pharmacists adapt to changing environment.
    Thompson CA
    Am J Health Syst Pharm; 2006 May; 63(9):798-802. PubMed ID: 16638938
    [No Abstract]   [Full Text] [Related]  

  • 38. What's Ahead for Health Care in 2018.
    Baldwin P
    Consult Pharm; 2018 Feb; 33(2):116. PubMed ID: 29409578
    [No Abstract]   [Full Text] [Related]  

  • 39. The pharmacist's responsibilities in skilled nursing facilities.
    Kidder SW
    Hosp Pharm; 1977 Nov; 12(11):547-8, 550. PubMed ID: 10305427
    [No Abstract]   [Full Text] [Related]  

  • 40. ASCP Comments on CMS Rule Overhauling Facility Requirements.
    Rankin P
    Consult Pharm; 2015 Oct; 30(10):624. PubMed ID: 26450145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.